 |
|
|
| |
PHARMACOKINETICS OF SIMEPREVIR, JNJ-56914845 AND
RITONAVIR-BOOSTED TMC647055 WHEN CO-ADMINISTERED IN HEALTHY VOLUNTEERS
|
| |
| |
Reported by Jules Levin
15th International Workshop on Clinical Pharmacology of HIV and Hepatitis Therapy. Washington DC, May 19-21, 2014
T.N. Kakuda,1 K. Spittaels,2 R. Verloes,2 I. Vanwelkenhuysen,3 C. Truyers,2 P. Van Remoortere1
1Janssen Research & Development LLC, Titusville, NJ, USA; 2Janssen Infectious Diseases, BVBA, Beerse, Belgium; 3Janssen Research & Development NV, Beerse, Belgium
|
| |
|
|
|
|
|
